High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

  1. Joseph, N.
  2. Cicchetti, A.
  3. McWilliam, A.
  4. Webb, A.
  5. Seibold, P.
  6. Fiorino, C.
  7. Cozzarini, C.
  8. Veldeman, L.
  9. Bultijnck, R.
  10. Fonteyne, V.
  11. Talbot, C.J.
  12. Symonds, P.R.
  13. Johnson, K.
  14. Rattay, T.
  15. Lambrecht, M.
  16. Haustermans, K.
  17. De Meerleer, G.
  18. Elliott, R.M.
  19. Sperk, E.
  20. Herskind, C.
  21. Veldwijk, M.
  22. Avuzzi, B.
  23. Giandini, T.
  24. Valdagni, R.
  25. Azria, D.
  26. Jacquet, M.-P.F.
  27. Charissoux, M.
  28. Vega, A.
  29. Aguado-Barrera, M.E.
  30. Gómez-Caamaño, A.
  31. Franco, P.
  32. Garibaldi, E.
  33. Girelli, G.
  34. Iotti, C.
  35. Vavassori, V.
  36. Chang-Claude, J.
  37. West, C.M.L.
  38. Rancati, T.
  39. Choudhury, A.
  40. REQUITE Consortium, null
  41. Show all authors +
Journal:
Frontiers in Oncology

ISSN: 2234-943X

Year of publication: 2022

Volume: 12

Type: Article

DOI: 10.3389/FONC.2022.937934 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus